TECH
Bio-Techne Corp
Bio-Techne Corp historical holders
total: 7
Weitz Value Fund Bio-Techne Corp transactions over time
- Total transactions:
- 2
- New positions:
- 1
- Reduced:
- 1
- Held since:
- 2025 Q1
- Held for:
- 5 quarters
- Latest activity:
- 2026 Q1
Wallace Weitz has been an institutional investor in Bio-Techne Corp (TECH) since 2025 Q1. According to 2026 Q1 report, Wallace Weitz holds 245,000 shares with a market value of roughly $12.80M representing 2.04% of their equity portfolio. The fund/company first acquired TECH in 2025 Q1, initially purchasing 300,000 shares. Since the initial investment, Weitz Value Fund has made 1 more transaction in this position.
Does Wallace Weitz still hold TECH?
Yes, Wallace Weitz continues to hold Bio-Techne Corp (TECH). According to their 2026 Q1 report, they maintain a position of 245,000 shares valued at approximately $12.80M, representing 2.04% of their equity portfolio.
When did Wallace Weitz first invest in TECH?
Wallace Weitz first invested in Bio-Techne Corp (TECH) in 2025 Q1 at the reported quarter-end price of $58.63 per share, acquiring 300,000 shares in their initial purchase.
What is Wallace Weitz's average cost basis for TECH?
Based on historical transaction data, Wallace Weitz's estimated cost basis for Bio-Techne Corp (TECH) is approximately $58.63 per share. This represents their average reported price* across all buy transactions.
Estimated cost basis*
- Weighted AVG buy price:
- $58.63
- Weighted AVG sell price:
- $52.26
TECH transactions history by Weitz Value Fund
2 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q1
|
2.04%
|
245,000
|
$52.26
|
$12,803,700
|
-18.33% (-55,000)
|
-0.38%
|
|
2025 Q1
|
2.05%
|
300,000
|
$58.63
|
$17,589,000
|
new
|
+2.05%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.